iCarbonX Pharmaceutical’s Antimicrobial Peptide Drug Candidate iCAMP016 Receives Clinical Trial Approval, Unleashing the Potential of Silicon-Based Chips + AI in Drug Discovery 2025-12-18 On December 17, 2025, iCAMP016 vaginal gel, an antimicrobial peptide Class I innovative drug…
CDX/MRD
Published: 10 August 2026
iCarbonX Pharmaceutical’s ….
Published: 23 July 2026
iCarbonX Pharmaceutical Initiates Phase I Clinical..
Published: 23 July 2026
IVD Reagent Products
Published: 19 August 2025
Diagnostic Instrument Portfolio
Published: 19 August 2025